OOIR: Observatory of International Research

Papers

(The H4-Index of Oncology Letters is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Resectability in bronchogenic carcinoma: A single‑center experience	63
A novel quantitative model based on gross tumor volume corresponding to anatomical distribution measured with multidetector computed tomography to determine the resectability of non‑distant metastatic	62
The impact of primary region resection on the therapeutic outcome of combination regimens for metastatic renal cell carcinoma	45
A novel fluorescent dye selectively images and kills cancer stem cells by targeting mitochondria: Evidence from a cell line‑based zebrafish xenograft model	41
Characteristic contrast‑enhanced ultrasound findings of hepatic epithelioid haemangioendothelioma: A case report and literature review	40
Targeting of FK506 binding protein 5 by miR‑203 affects the progression of breast cancer via regulating the fatty acid degradation pathway and potential drug‑repurposing	36
Clinical feasibility of modified procarbazine and lomustine chemotherapy without vincristine as a salvage treatment for recurrent adult glioma	35
Cadherin‑16 inhibits thyroid carcinoma cell proliferation and invasion	35
P4HA2 promotes cell proliferation and migration in glioblastoma	34
Long non‑coding RNA MIR17HG sponges microRNA‑21 to upregulate PTEN and regulate homoharringtonine‑based chemoresistance of acute myeloid leukemia cells	32
Response of human cancer cells to simultaneous treatment with sorafenib and radiofrequency current	31
Advances in transcriptomics and proteomics in differentiated thyroid cancer: An updated perspective (Review)	29
Cetuximab or nimotuzumab in combination with chemotherapy for treating recurrent/metastatic nasopharyngeal carcinoma: A meta‑analysis and systemic review	28
Effect of IFN‑γ encapsulated liposomes on major signal transduction pathways in the lymphocytes of patients with lung cancer	27
Prognostic value of circWWC3 as a novel survival‑related biomarker for clear cell renal cell carcinoma	27
Interferon‑induced protein 16 expression in colorectal cancer and its correlation with proliferation and immune signature markers	27
Novel predictive nomograms based on aspartate aminotransferase‑to‑platelet ratio index for hepatocellular carcinoma with post‑operative adjuvant transarterial chemoembolization	27
Synchronous primary colorectal mucinous adenocarcinoma and pancreatic ductal adenocarcinoma: A case report	27
Efficacy and outcome analysis: Combination of Endostar and chemotherapy as a neoadjuvant treatment of stage IIIA/IIIB squamous cell lung cancer	26
Pretreatment high cholesterol and low neutrophils predict complete pathological response after neoadjuvant short‑course radiotherapy followed by chemotherapy and immunotherapy in locally advanced rect	25
Mucosa‑associated lymphoid tissue in the central nervous system presenting as meningioma: A case report	25
[Retracted] Serum miR‑338‑5p has potential for use as a tumor marker for retinoblastoma	24
Synchronous ipsilateral papillary renal cell carcinoma and urothelial carcinoma: A case report	24
Single‑cell transcriptomic analysis revealed the tumor‑associated microenvironment of papillary thyroid carcinoma with metastasis	24
IDH2: A novel biomarker for environmental exposure in blood circulatory system disorders (Review)	24

[Corrigendum] Dihydroartemisinin suppresses proliferation, migration, the Wnt/β‑catenin pathway and EMT via TNKS in gastric cancer